Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Primaquine for Gametocyte Clearance in Asymptomatic Malaria
NCT01935882Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Sep 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of primaquine in Plasmodium falciparum malaria, sponsored by London School of Hygiene & Tropical Medicine. Started Sep 2013; status: completed.
02
Drugs
primaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01935882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01935882.